Medical Hair Encyclopedia
Dermatological pathologies and evidence-based clinical guidelines at international standards.
Anagen Effluvium (Acute and Drug-Induced Hair Loss) Diagnosis and Treatment Guide
📌 Patient Information Section: What Does This Condition Mean?
Anagen effluvium, unlike telogen effluvium, is a type of hair loss that occurs suddenly, severely, and extensively due to the direct suppression of hair production cells, not several months later, but days to 2 weeks after the trigger.
- Main Causes: Chemotherapy drugs used in cancer treatment, radiotherapy (radiation therapy) applied to the head and neck region, heavy metal poisoning, and certain acute immune system attacks.
- Is it Reversible?: In most cases of chemotherapy and radiotherapy (excluding specific high-dose irradiations), this hair loss is completely temporary. A few months after the treatment process is completed, hair follicles reactivate and begin to regrow with their former quality.
🩺 Clinical & Medical Guide for Physicians
- Diagnostic Criteria and Clinical Findings: Inquiry into the causative drug, radiation history, or toxic exposure. Sudden and dystrophic breakage and shedding of hairs from the shaft due to metabolic arrest of rapidly dividing anagen matrix cells.
- Management and Prevention Protocols:
- Scalp Cooling Technologies: Scalp cooling systems applied during chemotherapy can constrict hair follicle blood vessels, reducing drug delivery to the follicles and partially preventing hair loss. Additionally, specialized expertise and treatment approaches can be reviewed for clinical and surgical evaluations.
- Psychological and Supportive Approach: Informing the patient that the process is temporary and ensuring multidisciplinary follow-up.
Scientific References and Bibliography
- Saleh D, Nassereddin A, Saleh HM, Cook C. Anagen Effluvium. 2024 Apr 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29493918. PubMed Link
- Kanwar AJ, Narang T. Anagen effluvium. Indian J Dermatol Venereol Leprol. 2013 Sep-Oct;79(5):604-12. doi: 10.4103/0378-6323.116728. PMID: 23974578. PubMed Link
- Guerrero-Putz MD, Flores-Dominguez AC, Castillo-de la Garza RJ, Figueroa-Sanchez JA, Tosti A, Garza-Rodríguez V. Anagen Effluvium after Neurointerventional Radiation: Trichoscopy as a Diagnostic Ally. Skin Appendage Disord. 2022 Mar;8(2):102-107. doi: 10.1159/000518743. Epub 2021 Sep 14. PMID: 35419426; PMCID: PMC8928210. PubMed Link
Anagen Effluvium Frequently Asked Questions
What you need to know about acute and chronic hair loss, its causes, and modern approaches, with the expertise of Dr. Muhammet Özgehan's Clinic.
Anagen effluvium is a type of acute hair loss that develops as a result of sudden and severe toxic or metabolic damage to follicles in the active growth phase (anagen) of the hair cycle. Dr. Muhammet Özgehan states that this condition is typically triggered by factors that halt the mitotic activity of the roots, such as chemotherapy, severe toxic substances, or systemic shocks.
While telogen effluvium occurs when hairs prematurely enter the resting phase and shed several months later, in anagen effluvium, hairs shed very rapidly (usually within days) and suddenly while still in the growth phase. Dr. Muhammet Özgehan emphasizes that these two conditions must be definitively distinguished through accurate clinical diagnosis (trichoscopy).
In most cases, when the triggering factor (e.g., drug treatment or toxic exposure) is eliminated, hair roots retain their vitality and return to the growth phase. Dr. Muhammet Özgehan states that hair can regrow with appropriate supportive treatments, depending on the degree of root damage, but the process requires close monitoring.
Treatment focuses entirely on eliminating the underlying triggering cause. Clinical approaches applied under the supervision of Dr. Muhammet Özgehan include:
- Trigger Analysis: Detailed identification of systemic or medical causes.
- Root-Supporting PRP and Mesotherapy Cures: Treatments applied to nourish the micro-environment of hair follicles and accelerate cellular recovery during the healing process.
- Medical Follow-up: Dermatological support protocols that optimize the return of roots to the anagen phase.
Hair transplantation is absolutely not performed in cases of acute and active anagen effluvium. Dr. Muhammet Özgehan states that suitability can only be assessed through clinical examination after the primary cause has been completely eliminated and the hair cycle has achieved a stable and healthy balance for an extended period.